Moreover, SGLT-2 inhibitors are the only drug effective across the entire LVEF spectrum of HF, through postulated mechanisms that are not limited to the diuretic or natriuretic effects of the drug. This evidence concerns the gene SLC5A2 and hydrops fetalis.